$0.81-0.03 (-3.38%)
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. in the Healthcare sector is trading at $0.81. Wall Street consensus targets $7.50 (4 analysts), implying a +824.6% move over the next 12 months. The stock is currently near its 52-week low of $0.39, remaining 30.1% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful ...
Viewing insider transactions for Rani Therapeutics Holdings, Inc.'s ( NASDAQ:RANI ) over the last year, we see that...
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Rani Therapeutics (NASDAQ:RANI) executives highlighted what they described as a “transformational” 2025 during the company’s fourth-quarter and full-year earnings call, pointing to progress advancing its oral biologics delivery platform, the launch of a new clinical study, and a new strategic collab
Latest data shows the largest indicative borrow rate increases among liquid option names include: Starfighters Space, Inc. (FJET) 105.13% +2.83, GraniteShares 1.5x Long COIN Daily ETF (CONL) 11.48% +0.83, Icici Bank (IBN) 1.10% +0.80, EETH ETF (EETH) 19.93% +0.59, Tradr 2X Long IREN Daily ETF (IREX) 24.34% +0.56, iShares Investment Grade Corporate Bond ETF (LQD) 3.00% +0.55, Beyond Meat (BYND) 12.97% +0.49, Rani Therapeutics Holdings (RANI) 18.04% +0.44, Direxion Daily 20 plus Year Treasury Bear
Key Insights Rani Therapeutics Holdings' significant retail investors ownership suggests that the key decisions are...